This study reveals that BCKDK can localize within the nuclei of breast cancer cells, where it binds to and phosphorylates RNF8, thereby inhibiting the ubiquitin‐mediated degradation of RAD51. The gene discussed is RNF8; the disease is breast carcinoma.